B. Evers
发表
R. Bernards,
R. Beijersbergen,
Wipawadee Grernrum,
2016,
Nature Biotechnology.
T. Helleday,
J. Jonkers,
B. Evers,
2010,
Trends in pharmacological sciences.
T. Helleday,
M. Harms-Ringdahl,
S. Haghdoost,
2014,
Proteomes.
E. Sonnhammer,
O. Frings,
T. Helleday,
2015,
Cell Discovery.
B. Evers,
2009
.
D. Adams,
D. Egan,
J. Jonkers,
2009,
Clinical Cancer Research.
R. Bernards,
R. Beijersbergen,
S. Mainardi,
2017,
Cell reports.
J. Jonkers,
S. Pettitt,
C. Lord,
2018,
Cell reports.
Sridhar Ramaswamy,
Ben S. Wittner,
Fabien Reyal,
2013,
Proceedings of the National Academy of Sciences.
R. Bernards,
A. Houtsmuller,
M. V. van Royen,
2022,
Nature Communications.
T. Severson,
W. Zwart,
R. Medema,
2022,
Nucleic acids research.
M. Lohuizen,
J. Jonkers,
A. A. Prasad,
2009
.
D. Egan,
B. Rodenko,
H. Ovaa,
2009
.
M. Pajic,
A. Lau,
M. O’Connor,
2017
.
M. Pajic,
A. Lau,
M. O’Connor,
2016,
Cancer research.
Jos Jonkers,
Robert D Cardiff,
Bastiaan Evers,
2006,
Cancer cell.
G. Mills,
R. Bernards,
C. Sotiriou,
2016,
Clinical Cancer Research.
R. Bernards,
R. Beijersbergen,
S. Mainardi,
2019,
Nature.
Qiang Yu,
P. Nederlof,
J. Jonkers,
2009,
Breast Cancer Research.
Anirudh Prahallad,
Stefan M Willems,
Bastiaan Evers,
2014,
Cell reports.
A. Lau,
M. O’Connor,
J. Jonkers,
2008,
Clinical Cancer Research.
A. Lau,
M. O’Connor,
J. Jonkers,
2008
.
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
J. Jonkers,
B. Evers,
Jos Jonkers,
2006,
Oncogene.
M. Lohuizen,
J. Jonkers,
A. A. Prasad,
2008,
Current Biology.
Richard Svensson,
Robert Gustafsson,
Hanna Axelsson,
2014,
Nature.
Link,
B. Evers,
Link,
2022
.
John J. Wyrick,
J. Wyrick,
R. Bernards,
2021,
Nature Cell Biology.
J. Jonkers,
S. Pettitt,
C. Lord,
2018,
Cell reports.
J. Jonkers,
E. Speksnijder,
M. Ciampricotti,
2010,
The Journal of pathology.
J. Jonkers,
K. E. Visser,
E. Speksnijder,
2009
.
R. Bernards,
R. Beijersbergen,
Wenxin Qin,
2018,
Cell Research.
R. Bernards,
R. Beijersbergen,
Wenxin Qin,
2018,
Journal of hepatology.
A. Jochemsen,
B. van de Water,
A. Teunisse,
2009,
Atherosclerosis.
R. Bernards,
T. Severson,
A. V. D. Van Der Zee,
2018,
Oncogene.
Katarzyna Jastrzebski,
Bastiaan Evers,
Roderick L Beijersbergen,
2016,
Methods in molecular biology.
T. Helleday,
O. Mortusewicz,
B. Evers,
2016,
Oncogene.
Phospho-ERK is a response biomarker to a combination of sorafenib and MEK inhibition in liver cancer
R. Bernards,
R. Beijersbergen,
Wenxin Qin,
2018,
bioRxiv.
Bastiaan Evers,
Roderick L Beijersbergen,
R. Bernards,
2014,
Molecular systems biology.
R. Bernards,
R. Beijersbergen,
Wenxin Qin,
2018,
Journal of hepatology.
R. Bernards,
R. Beijersbergen,
Wenxin Qin,
2018,
Cell Research.
Correction: Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
P. Artursson,
E. Homan,
T. Lundbäck,
2017,
Nature.
T. Helleday,
E. Homan,
T. Lundbäck,
2022
.